New in psychedelics: Study says ibogaine and psilocybin hold potential to treat addiction

Related Articles

FormattedPicture

BUSINESS NEWS

Natural ingredient manufacturer Alland & Robert signs the We Use Wild pledge, created by NGO TRAFFIC, a specialist in wild plant trade. The company aims to address... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Psychedelics are gaining popularity in the mental health space for their potential therapeutic effects on the brain, treatment-resistant depression and addiction. We... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Amid a significant growth spurt in the demand for weight management products, the segment demonstrates a progression from supplementation toward healthier lifestyle... Read More

FormattedPicture

BUSINESS NEWS

US-based Landkind, a subsidiary of Double Rainbow Biosciences, has received GRAS approval (Generally Recognized As Safe) for its dietary supplement LK-01 consisting of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

NutritionInsight looks back at the biggest industry developments of the year. From the US infant formula shortage to rising inflation, it was a year filled with... Read More

trans